Laser Atherectomy Devices Market Report 2026

Laser Atherectomy Devices Market Overview

• Laser Atherectomy Devices market size has reached to $1.3 billion in 2025 • Expected to grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: The Surge In Cardiovascular Diseases And Its Impact On The Laser Atherectomy Devices Market • Market Trend: Advances In The Laser Atherectomy Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Laser Atherectomy Devices Market?

A laser atherectomy device refers to a medical instrument that uses laser energy to break down and remove blockages from blood vessels. It is commonly used to treat conditions such as peripheral artery disease (PAD) or atherosclerosis, which are caused by the buildup of plaque in the arteries. The device works by delivering a high-energy laser beam to the plaque, which vaporizes and removes the blockage. The main types of laser atherectomy devices are computer control and others. Computer control refers to the use of computer technology to control and manage various systems and processes. These are used for several applications, including cardiovascular, peripheral vascular, and neurovascular, and are used by hospitals and surgical centers, ambulatory care centers, and others.

What Is The Laser Atherectomy Devices Market Growth Forecast?

The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, growing focus on reducing restenosis rates. Major trends in the forecast period include increasing adoption of laser-based plaque removal techniques, rising use of computer-controlled atherectomy systems, growing demand for minimally invasive vascular interventions, expansion of peripheral and neurovascular applications, enhanced focus on precision and procedural safety.

What Is The Driver Of The Laser Atherectomy Devices Market?

The rise in cardiovascular diseases is expected to boost the growth of the laser atherectomy devices market going forward. Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels, commonly affecting the circulatory system. A rise in cardiovascular diseases results in a larger pool of patients requiring treatment for arterial occlusions and atherosclerotic plaque, creating a greater demand for laser atherectomy devices. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rise in cardiovascular diseases is driving the growth of the laser atherectomy devices industry.

Key Players In The Global Laser Atherectomy Devices Market

Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc

Global Laser Atherectomy Devices Market Trends and Insights

Major companies operating in the laser atherectomy devices market are developing advanced solutions such as atherectomy platforms to meet larger customer bases, more sales, and increase revenue. An atherectomy platform refers to a comprehensive system or set of tools designed for the treatment of atherosclerosis, a medical condition characterized by the buildup of plaque in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored for clearing plaque blockages in leg arteries. This exclusive, catheter-based design utilizes angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall, both during advancement and retraction, through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This novel approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.

What Are Latest Mergers And Acquisitions In The Laser Atherectomy Devices Market?

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. As a result of the acquisition, Abbott gains a complementary solution for addressing vascular disease, incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, thereby restoring blood flow. This strategic move, acquiring CSI, is part of Abbott's broader investment in its vascular portfolio, strengthening their capacity to provide comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc. is a US-based manufacturer of atherectomy devices.

What Defines the Laser Atherectomy Devices Market?

The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Laser Atherectomy Devices Market Report 2026?

The laser atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.